Pharmacological inhibition of PERK prevented reductions in Nav1.5, Kv4.3, and Kv1.5 channel proteins while resulting in shortened QTc intervals, fewer episodes of VAs, reduced mortality rates, and diminished overall arrhythmia risk in MI mouse models [52]. The gene discussed is SCN5A; the disease is cardiac arrhythmia.